COVID Vaccine Sales Of AstraZeneca Hit $1.2 Billion In First 6 Months

British pharmaceuticals giant AstraZeneca on Thursday said that its COVID vaccine sales generated $1.2 billion in the first 6 months of the year.

They said in a results statement that they shipped about 319 million doses worldwide. It included $572 million sales in Europe and $455 million in emerging markets.